Hobart W -

A significant portion of his work involves the early diagnosis and management of cutaneous melanoma. He has contributed to the BMJ Best Practice regarding skin cancer, emphasizing the "ABCD" criteria (Asymmetry, Border irregularity, Color variability, Diameter >6mm) and the "ugly duckling" sign for identifying suspicious lesions.

Dr. Walling is a fellowship-trained Mohs surgeon. His research includes identifying factors associated with "complex" Mohs cases—those requiring four or more surgical stages to fully excise skin cancer while sparing healthy tissue. Hobart W

Dr. Walling has extensively researched PHH, a condition characterized by excessive sweating beyond what is necessary for thermoregulation. He helped establish diagnostic criteria for PHH, which include bilateral and symmetric sweating, episodes at least weekly, and onset before age 25. His research also highlights that PHH increases the risk of cutaneous infections. A significant portion of his work involves the

Hobart W. Walling is a highly regarded dermatologist based in Coralville, Iowa, known for his clinical expertise and prolific research. His work primarily focuses on complex skin conditions and dermatological surgery. Walling is a fellowship-trained Mohs surgeon

His research portfolio includes studies on alpha-1-antitrypsin deficiency panniculitis and adult-onset clinically amyopathic dermatomyositis. Hobart W. Harris, MD, MPH: Surgical Innovator Alpha-1-antitrypsin associated panniculitis: The MS variant

The following feature examines the career of , a prominent figure in the field of dermatology, and Hobart W. Harris , a distinguished surgeon. Both individuals have made significant contributions to their respective medical fields through extensive research and clinical practice. Hobart W. Walling, MD, PhD: Dermatological Pioneer